BACKGROUND: Little detailed knowledge is available regarding the etiology and outcome of CNS infection, particularly in HIV-infected individuals, in low-resource settings. METHODS: From January 2015 to April 2016, we prospectively included all adults with suspected CNS infection in a referral hospital in Jakarta, Indonesia. Systematic screening included HIV testing, CSF examination, and neuroimaging. RESULTS: A total of 274 patients with suspected CNS infection (median age 26 years) presented after a median of 14 days with headache (77%), fever (78%), seizures (27%), or loss of consciousness (71%). HIV coinfection was common (54%), mostly newly diagnosed (30%) and advanced (median CD4 cell count 30/µL). Diagnosis was established in 167 participants (65%), including definite tuberculous meningitis (TBM) (n = 44), probable TBM (n = 48), cerebral toxoplasmosis (n = 48), cryptococcal meningitis (n = 14), herpes simplex virus/varicella-zoster virus/cytomegalovirus encephalitis (n = 10), cerebral lymphoma (n = 1), neurosyphilis (n = 1), and mucormycosis (n = 1). In-hospital mortality was 32%; 6-month mortality was 57%. The remaining survivors had either moderate or severe disability (36%) according to Glasgow Outcome Scale. CONCLUSION: In this setting, patients with CNS infections present late with severe disease and often associated with advanced HIV infection. Tuberculosis, toxoplasmosis, and cryptococcosis are common. High mortality and long-term morbidity underline the need for service improvements and further study.
BACKGROUND: Little detailed knowledge is available regarding the etiology and outcome of CNS infection, particularly in HIV-infected individuals, in low-resource settings. METHODS: From January 2015 to April 2016, we prospectively included all adults with suspected CNS infection in a referral hospital in Jakarta, Indonesia. Systematic screening included HIV testing, CSF examination, and neuroimaging. RESULTS: A total of 274 patients with suspected CNS infection (median age 26 years) presented after a median of 14 days with headache (77%), fever (78%), seizures (27%), or loss of consciousness (71%). HIV coinfection was common (54%), mostly newly diagnosed (30%) and advanced (median CD4 cell count 30/µL). Diagnosis was established in 167 participants (65%), including definite tuberculous meningitis (TBM) (n = 44), probable TBM (n = 48), cerebral toxoplasmosis (n = 48), cryptococcal meningitis (n = 14), herpes simplex virus/varicella-zoster virus/cytomegalovirus encephalitis (n = 10), cerebral lymphoma (n = 1), neurosyphilis (n = 1), and mucormycosis (n = 1). In-hospital mortality was 32%; 6-month mortality was 57%. The remaining survivors had either moderate or severe disability (36%) according to Glasgow Outcome Scale. CONCLUSION: In this setting, patients with CNS infections present late with severe disease and often associated with advanced HIV infection. Tuberculosis, toxoplasmosis, and cryptococcosis are common. High mortality and long-term morbidity underline the need for service improvements and further study.
Authors: Allan R Tunkel; Barry J Hartman; Sheldon L Kaplan; Bruce A Kaufman; Karen L Roos; W Michael Scheld; Richard J Whitley Journal: Clin Infect Dis Date: 2004-10-06 Impact factor: 9.079
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Julia Granerod; Helen E Ambrose; Nicholas Ws Davies; Jonathan P Clewley; Amanda L Walsh; Dilys Morgan; Richard Cunningham; Mark Zuckerman; Ken J Mutton; Tom Solomon; Katherine N Ward; Michael Pt Lunn; Sarosh R Irani; Angela Vincent; David Wg Brown; Natasha S Crowcroft Journal: Lancet Infect Dis Date: 2010-10-15 Impact factor: 25.071
Authors: A Rizal Ganiem; Ida Parwati; Rudi Wisaksana; Adri van der Zanden; Diederik van de Beek; Patrick Sturm; Andre van der Ven; Bachti Alisjahbana; Anne-Marie Brouwer; Nani Kurniani; Jan de Gans; Reinout van Crevel Journal: AIDS Date: 2009-11-13 Impact factor: 4.177
Authors: P Portegies; L Solod; P Cinque; A Chaudhuri; J Begovac; I Everall; T Weber; M Bojar; P Martinez-Martin; P G E Kennedy Journal: Eur J Neurol Date: 2004-05 Impact factor: 6.089
Authors: Suzaan Marais; Guy Thwaites; Johan F Schoeman; M Estée Török; Usha K Misra; Kameshwar Prasad; Peter R Donald; Robert J Wilkinson; Ben J Marais Journal: Lancet Infect Dis Date: 2010-09-06 Impact factor: 25.071
Authors: Kenneth Plante; Eryu Wang; Charalambos D Partidos; James Weger; Rodion Gorchakov; Konstantin Tsetsarkin; Erin M Borland; Ann M Powers; Robert Seymour; Dan T Stinchcomb; Jorge E Osorio; Ilya Frolov; Scott C Weaver Journal: PLoS Pathog Date: 2011-07-28 Impact factor: 6.823
Authors: Suzaan Marais; Fiona V Cresswell; Rovina Ruslami; David B Meya; Raph L Hamers; Lindsey H M Te Brake; Ahmad R Ganiem; Darma Imran; Ananta Bangdiwala; Emily Martyn; John Kasibante; Enock Kagimu; Abdu Musubire; Kartika Maharani; Riwanti Estiasari; Ardiana Kusumaningrum; Nadytia Kusumadjayanti; Vycke Yunivita; Kogieleum Naidoo; Richard Lessells; Yunus Moosa; Elin M Svensson; Katherine Huppler Hullsiek; Rob E Aarnoutse; David R Boulware; Reinout van Crevel Journal: Wellcome Open Res Date: 2020-08-25